Both [68Ga]Ga-FAPI and [18F]FDG PET/CT missed bone metastasis in a patient with breast cancer

被引：0
|
作者：
Shan Zheng
Yun Chen
Youzhi Zhu
Shaobo Yao
Weibing Miao
机构：
[1] The First Affiliated Hospital of Fujian Medical University,Department of Nuclear Medicine
[2] The First Affiliated Hospital of Fujian Medical University,Department of Thyroid and Breast Surgery
[3] The First Affiliated Hospital of Fujian Medical University,Fujian Provincial Key Laboratory of Precision Medicine for Cancer
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4519 / 4520
页数：1
相关论文
共 50 条
  • [41] The added value of [68Ga]Ga-DOTA-FAPI-04 PET/CT in pancreatic cancer: a comparison to [18F]F-FDG
    Liu, Qiufang
    Shi, Si
    Liu, Shuai
    Xu, Xiaoping
    Hu, Silong
    Zhang, Ji
    Wang, Chunmei
    Yu, Xianjun
    Song, Shaoli
    EUROPEAN RADIOLOGY, 2023, 33 (07) : 5007 - 5016
  • [42] The added value of [68Ga]Ga-DOTA-FAPI-04 PET/CT in pancreatic cancer: a comparison to [18F]F-FDG
    Qiufang Liu
    Si Shi
    Shuai Liu
    Xiaoping Xu
    Silong Hu
    Ji Zhang
    Chunmei Wang
    Xianjun Yu
    Shaoli Song
    European Radiology, 2023, 33 : 5007 - 5016
  • [43] Comparison of Diagnostic Efficacy of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT for Staging and Restaging of Gastric Cancer
    Zhang, Shumao
    Wang, Wei
    Xu, Tingting
    Ding, Haoyuan
    Li, Yi
    Liu, Huipan
    Huang, Yinxue
    Liu, Lin
    Du, Tao
    Zhao, Yan
    Chen, Yue
    Qiu, Lin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Cancer Integrin Imaging with [68Ga]Ga-Trivehexin PET/ CT for a Patient with Breast Cancer and Neuroendocrine Neoplasm: A case both [18F]FDG and [68Ga]Ga-DOTATATE positive but [68Ga]Ga-Trivehexin PET for Integrin avß6 negative lesion
    Beydagi, G.
    Alan-Selcuk, N.
    Akcay, K.
    Caner, B.
    Yaprak, O.
    Kalayci, M.
    Kabasakal, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S907 - S908
  • [45] Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT
    Liang Zhao
    Yizhen Pang
    Zuoming Luo
    Kaili Fu
    Tingting Yang
    Long Zhao
    Long Sun
    Hua Wu
    Qin Lin
    Haojun Chen
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1944 - 1955
  • [46] Head-to-head comparison of [68Ga]Ga-FAPI PET and [18F]FDG PET in the detection of bone and lymph node metastasis in various cancers: A systematic review and meta-analysis
    Wu, Guiyou
    Wang, Daofeng
    Zhang, Wupeng
    Jia, Zhengfeng
    Li, Jiantao
    Zhang, Licheng
    EUROPEAN JOURNAL OF RADIOLOGY, 2024, 171
  • [47] Superiority of [68Ga]Ga-DOTA-FAPI-04 PET/CT to [18F]FDG PET/CT in the evaluation of thymic epithelial tumours
    Xiuling Shen
    Xin Zhou
    Yuan Yao
    Xiangxi Meng
    Yufei Song
    Zhi Yang
    Nan Li
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3414 - 3424
  • [48] Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings
    Chen, Haojun
    Zhao, Liang
    Ruan, Dan
    Pang, Yizhen
    Hao, Bing
    Dai, Yaqing
    Wu, Xiurong
    Guo, Wei
    Fan, Chunlei
    Wu, Jingxun
    Huang, Weipeng
    Lin, Qin
    Sun, Long
    Wu, Hua
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (01) : 73 - 86
  • [49] Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT
    Zhao, Liang
    Pang, Yizhen
    Luo, Zuoming
    Fu, Kaili
    Yang, Tingting
    Zhao, Long
    Sun, Long
    Wu, Hua
    Lin, Qin
    Chen, Haojun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 1944 - 1955
  • [50] Superiority of [68Ga]Ga-DOTA-FAPI-04 PET/CT to [18F]FDG PET/CT in the evaluation of thymic epithelial tumours
    Shen, Xiuling
    Zhou, Xin
    Yao, Yuan
    Meng, Xiangxi
    Song, Yufei
    Yang, Zhi
    Li, Nan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3414 - 3424
12345